期刊文献+

持续小剂量他达拉非联合按需口服西地那非治疗勃起功能障碍的疗效及安全性研究 被引量:4

下载PDF
导出
摘要 目的:评估持续小剂量口服他达拉非联合按需口服小剂量西地那非治疗男性勃起功能障碍(ED)的疗效及安全性。方法:将107例ED患者随机分为2组:单独服用他达拉非组(57例,他达拉非5 mg每日1次口服)和他达拉非加服用西地那联合组(50例,他达拉非5 mg每日1次口服,西地那非50 mg按需口服)。分别治疗12周,记录两组患者国际勃起功能指数(IIEF-5)评分,并评估药物的安全性。结果:单用他达拉非和他达拉非联合按需服用西地那非均能明显改善ED患者勃起功能,两组间IIEF-5评分改变比较无差异(P>0.05),其中联合用药对重度ED患者的IIEF-5评分改变两组间有明显统计学差异(P<0.05)。IIEF-5评分问题2(达到勃起能力即插入成功率)治疗前后两组评分改变差异有统计学意义(P<0.05)。结论:每日5 mg他达拉非加按需50 mg西地那非联合服用更能够使患者较快达到满意勃起硬度,同时通过修复血管内皮功能达到从根本治疗ED的目的,尤其对重度ED患者能达到较好的疗效。
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2013年第9期1274-1276,共3页 Journal of Nanjing Medical University(Natural Sciences)
基金 国家自然科学基金资助(81270685)
  • 相关文献

参考文献13

  • 1AytaIA, McKinlay JB, Krane RJ. The likely worldwide in- crease in erectile dysfunction between 1995 and 2025 and some possible policy consequences[J].BJU Int,1999,84(1) :50-56.
  • 2Wespes E,Amar E,Hatzichristou D,et al. EAU Guide- lines on erectile dysfunction:an update [J]. Eur Urol, 2006,49(5) :806-815.
  • 3Seflel A,Goldfischer E,Kim ED,et al. Onset of efficacy of tadalafil once daily in men with erectile dysfunction:a randomized,double-blind,placebo controlled trial [J]. J Urol,2011,185(1) :243-248.
  • 4Althof SE, Rubio-Aurioles E, Kingsberg S, et al. Impact of tadalafil once daily in men with erectile dysfunction--in- cluding a report of the partners' evaluation[J]. Urology, 2010,75(6) : 1358-1363.
  • 5Cheng E. Real-life safety and efficacy of Vardenafil in the treatment of erectile dysfunction-results from 30010 U.S. Patients[J]. J Sex Med.2007.4(2) :432-439.
  • 6徐伟东,刘智勇,叶华茂,鲁欣,许传亮,纪家涛,朴曙光,盛夏.长期小剂量服用他达拉非治疗男性勃起功能障碍的疗效及不良反应[J].中华男科学杂志,2011,17(6):531-534. 被引量:12
  • 7西地那非Ⅳ期临床研究组.西地那非治疗勃起功能障碍的安全性和疗效的临床应用研究[J].中华泌尿外科杂志,2003,24(2):134-137. 被引量:16
  • 8Hatzichristou D, Gambla M, Rubio-Aurioles E, et al. Effi- cacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction [ J ]. Diabet Medl, 2008,25 (2) : 138-146.
  • 9Mekinlay Melnik T,Abdo CH,de Moraes JF,et al. Satis- faction with the treatment,confidence and 'naturalness' in engaging in sexual activity in men with psychogenic erectile dysfunction :preliminary results of a randomized controlled trial of three therapeutic approaches [J]. BJU Int, 2012,109(8) : 1213-1219.
  • 10Corona G, Mondaini N, Ungar A,et al. Phosphodiesterase type 5 (PDE5) inhibitors in erectile dysfunction:the proper drug for the proper patient[J]. J Sex Med,2011,8 (12) :3418-3432.

二级参考文献11

  • 1朱选文,李方印,方家杰.他达拉非治疗勃起功能障碍的疗效和安全性临床观察(附80例报告)[J].中华男科学杂志,2006,12(5):421-423. 被引量:13
  • 2陈志勇,陈映鹤,竺海波,何有华,张磊,杨世坤.西地那非对夜间勃起作用的研究[J].中华男科学杂志,2006,12(8):706-707. 被引量:3
  • 3NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA, 1993, 270( 1 ) : 83-90.
  • 4Wespes E, Amar E, Hatzichristou D, et al. EAU guidelines on erectile dysfunction : An update. Ear Urol, 2006, 49 (5) : 806- 815.
  • 5Hatzichristou D, Gambla M, Rubio-Aurioles E, et al. Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction. Diabet Med, 2008, 25(2): 138-146.
  • 6Cour F, Fabbro-Perray P, Cuzin B, et al. Recommendations to general practice doctors for first line management of erectile dysfunction. Prog Urol, 2005, 15(6): 1011-1020.
  • 7Dean J, Hackett GI, Gentile V, et al. Psychosocial outcomes and drug attributes affecting treatment choice in men receiving sildenafil citrate and tadalafil for the treatment of erectile dysfunction : Results of a multicenter, randomized, open-label, crossover study. J Sex Med, 2006, 3(4) : 650-661.
  • 8Costa P, Grivel T, Gehchan N. Tadalafil once daily in the management of erectile dysfunction: Patient and partner perspectives. Patient Prefer Adherence, 2009, 3 : 105-111.
  • 9Rosen RC, Riley A, Wagner G, et al. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology, 1997, 49(6) : 822-830.
  • 10李飞,周其赵,李铁求,邹亚光,毛向明.小剂量服用他达拉非对阴茎夜间勃起作用的研究[J].中华男科学杂志,2009,15(8):730-732. 被引量:4

共引文献26

同被引文献46

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部